Posts in tag
True North Therapeutics
True North Therapeutics Inks $35M Series B
What does True North Therapeutics do? True North Therapeutics, is a pioneering biotechnology company which selectively inhibits the complement pathway for diseases with high unmet clinical necessity. True North Therapuetics’s monoclonal antibody, TNT009, targets the Classical Complement Pathway, enabling the selective inhibition of downstream phagocytosis, cell lysis and inflammation. This biotech company is currently focusing …